These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19759232)

  • 1. Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient.
    Delaugerre C; Denis B; Peytavin G; Palmer P; Mourez T; Le Goff J; Molina JM; Simon F
    J Clin Microbiol; 2009 Nov; 47(11):3763-4. PubMed ID: 19759232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV encephalitis in a patient on antiretroviral therapy: a case report.
    Hlebowicz M; Parczewski M; Jakubowski P
    Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral escape in cerebrospinal fluid--an achilles heel of HIV therapy?
    Clifford DB
    J Infect Dis; 2010 Dec; 202(12):1768-9. PubMed ID: 21050117
    [No Abstract]   [Full Text] [Related]  

  • 4. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of raltegravir-resistant HIV-1 in the central nervous system.
    Watanabe K; Honda M; Watanabe T; Tsukada K; Teruya K; Kikuchi Y; Oka S; Gatanaga H
    Int J STD AIDS; 2010 Dec; 21(12):840-1. PubMed ID: 21297097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
    Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
    Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
    Edén A; Nilsson S; Hagberg L; Fuchs D; Zetterberg H; Svennerholm B; Gisslén M
    J Infect Dis; 2016 Dec; 214(12):1822-1825. PubMed ID: 27683820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV encephalitis related to the development of a discordant resistant virus in CNS.
    Pérez-Rodríguez MT; Sousa A; Martínez-Cueto P; Ocampo A
    Clin Microbiol Infect; 2015 Aug; 21(8):e59-60. PubMed ID: 25980354
    [No Abstract]   [Full Text] [Related]  

  • 9. The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis.
    Bossi P; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
    Clin Infect Dis; 1998 May; 26(5):1072-3. PubMed ID: 9597227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid.
    van Lelyveld SF; Nijhuis M; Baatz F; Wilting I; van den Bergh WM; Kurowski M; de Jong D; Hoepelman AI; Wensing AM
    Clin Infect Dis; 2010 Feb; 50(3):387-90. PubMed ID: 20047481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Sequencing of HIV-1 in Cerebrospinal Fluid.
    Tong CY; Costelloe S; Hubb J; Mullen J; O'Shea S; Marta M; Kulasegaram R; Rackstraw S
    Clin Infect Dis; 2015 Sep; 61(6):1022-5. PubMed ID: 26021989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy.
    Cornelissen M; Back NK; Burger DM; Blom P; Portegies P; Prins JM; van der Valk M
    Antivir Ther; 2011; 16(6):931-5. PubMed ID: 21900726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
    Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J
    Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
    Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
    J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
    Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
    J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of HIV-1 resistance mutations in cerebrospinal fluid from persons receiving suppressive therapy.
    Seligman SJ
    J Infect Dis; 2011 Jul; 204(1):174; author reply 174-5. PubMed ID: 21628673
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
    Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
    Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
    Strain MC; Letendre S; Pillai SK; Russell T; Ignacio CC; Günthard HF; Good B; Smith DM; Wolinsky SM; Furtado M; Marquie-Beck J; Durelle J; Grant I; Richman DD; Marcotte T; McCutchan JA; Ellis RJ; Wong JK
    J Virol; 2005 Feb; 79(3):1772-88. PubMed ID: 15650202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
    Soulie C; Grudé M; Descamps D; Amiel C; Morand-Joubert L; Raymond S; Pallier C; Bellecave P; Reigadas S; Trabaud MA; Delaugerre C; Montes B; Barin F; Ferré V; Jeulin H; Alloui C; Yerly S; Signori-Schmuck A; Guigon A; Fafi-Kremer S; Haïm-Boukobza S; Mirand A; Maillard A; Vallet S; Roussel C; Assoumou L; Calvez V; Flandre P; Marcelin AG;
    J Antimicrob Chemother; 2017 Aug; 72(8):2351-2354. PubMed ID: 28472307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis.
    Di Stefano M; Monno L; Fiore JR; Angarano G
    AIDS; 1997 Jan; 11(1):133-5. PubMed ID: 9110095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.